EGR1 was also reported as a potential biomarker to differentiate major psychoses, as its upregulation in fibroblasts and peripheral blood cells was specific to schizophrenia compared to Major Depressive Disorder (MDD) and Bipolar Disorder (BD)51. This evidence concerns the gene EGR1 and bipolar disorder.